The year 2019 in the European Heart Journal-Cardiovascular Imaging: Part I.

cardiac magnetic resonance computer tomography echocardiography nuclear cardiology

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
20 10 2020
Historique:
received: 24 08 2020
accepted: 27 08 2020
pubmed: 16 9 2020
medline: 29 6 2021
entrez: 15 9 2020
Statut: ppublish

Résumé

The European Heart Journal-Cardiovascular Imaging was launched in 2012 and has during these years become one of the leading multimodality cardiovascular imaging journals. The journal is now established as one of the top cardiovascular journals and is the most important cardiovascular imaging journal in Europe. The most important studies published in our Journal in 2019 will be highlighted in two reports. Part I of the review will focus on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging, while Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease.

Identifiants

pubmed: 32929466
pii: 5905662
doi: 10.1093/ehjci/jeaa259
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1208-1215

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Thor Edvardsen (T)

Department of Cardiology, Centre of Cardiological Innovation, Oslo University Hospital, Rikshospitalet, Postbox 4950 Nydalen, Sognsvannsveien 20, NO-0424 Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Postboks 1171, Blindern 0318 Oslo, Norway.

Kristina H Haugaa (KH)

Department of Cardiology, Centre of Cardiological Innovation, Oslo University Hospital, Rikshospitalet, Postbox 4950 Nydalen, Sognsvannsveien 20, NO-0424 Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Postboks 1171, Blindern 0318 Oslo, Norway.

Steffen E Petersen (SE)

Barts Heart Centre, Barts Health NHS Trust, West Smithfield, EC1A 7BE, London, UK.
William Harvey Research Institute, Queen Mary University of London, EC1M 6BQ, London, UK.

Alessia Gimelli (A)

Fondazione Toscana Gabriele Monasterio via Moruzzi n.1 - 56124 - Pisa, Italy.

Erwan Donal (E)

Cardiology and CIC-IT1414, CHU Rennes, Rennes, France.
LTSI INSERM 1099, University Rennes-1, Rennes, France.

Gerald Maurer (G)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Wien, Austria.

Bogdan A Popescu (BA)

Department of Cardiology, University of Medicine and Pharmacy "Carol Davila"-Euroecolab, Emergency Institute for Cardiovascular Diseases "Prof. Dr. C. C. Iliescu", Sos. Fundeni 258, Sector 2, 022328 Bucharest, Romania.

Bernard Cosyns (B)

Cardiology, CHVZ (Centrum voor Hart en Vaatziekten), ICMI (In Vivo Cellular and Molecular Imaging) Laboratory, Universitair Ziekenhuis Brussel, 109 Laarbeeklaan, B1090 Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH